KHTRF
Price
$4.46
Change
+$0.02 (+0.45%)
Updated
May 2 closing price
Capitalization
390.53M
TAK
Price
$14.10
Change
+$0.10 (+0.71%)
Updated
May 16, 04:59 PM (EDT)
Capitalization
43.11B
74 days until earnings call
Ad is loading...

KHTRF vs TAK

Header iconKHTRF vs TAK Comparison
Open Charts KHTRF vs TAKBanner chart's image
Knight Therapeutics
Price$4.46
Change+$0.02 (+0.45%)
Volume$2.7K
Capitalization390.53M
Takeda Pharmaceutical
Price$14.10
Change+$0.10 (+0.71%)
Volume$26.62K
Capitalization43.11B
KHTRF vs TAK Comparison Chart
Loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KHTRF vs. TAK commentary
May 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KHTRF is a Hold and TAK is a Hold.

Ad is loading...
COMPARISON
Comparison
May 17, 2025
Stock price -- (KHTRF: $4.46 vs. TAK: $14.00)
Brand notoriety: KHTRF and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KHTRF: 63% vs. TAK: 79%
Market capitalization -- KHTRF: $390.53M vs. TAK: $43.11B
KHTRF [@Pharmaceuticals: Other] is valued at $390.53M. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KHTRF’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • KHTRF’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than KHTRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TAK’s TA Score shows that 4 TA indicator(s) are bullish.

  • TAK’s TA Score: 4 bullish, 5 bearish.

Price Growth

KHTRF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while TAK (@Pharmaceuticals: Other) price change was -1.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.72%. For the same industry, the average monthly price growth was +12.60%, and the average quarterly price growth was +27.89%.

Reported Earning Dates

TAK is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.72% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($43.1B) has a higher market cap than KHTRF($391M). KHTRF has higher P/E ratio than TAK: KHTRF (39.84) vs TAK (36.79). KHTRF YTD gains are higher at: 23.546 vs. TAK (5.740). TAK has higher annual earnings (EBITDA): 1.01T vs. KHTRF (44M). TAK has more cash in the bank: 317B vs. KHTRF (183M). KHTRF has less debt than TAK: KHTRF (82.6M) vs TAK (4.66T). TAK has higher revenues than KHTRF: TAK (4.17T) vs KHTRF (312M).
KHTRFTAKKHTRF / TAK
Capitalization391M43.1B1%
EBITDA44M1.01T0%
Gain YTD23.5465.740410%
P/E Ratio39.8436.79108%
Revenue312M4.17T0%
Total Cash183M317B0%
Total Debt82.6M4.66T0%
FUNDAMENTALS RATINGS
KHTRF vs TAK: Fundamental Ratings
KHTRF
TAK
OUTLOOK RATING
1..100
4958
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9084
PRICE GROWTH RATING
1..100
4358
P/E GROWTH RATING
1..100
9718
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for KHTRF (70) in the null industry. This means that TAK’s stock grew somewhat faster than KHTRF’s over the last 12 months.

TAK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as KHTRF (100) in the null industry. This means that TAK’s stock grew similarly to KHTRF’s over the last 12 months.

TAK's SMR Rating (84) in the Pharmaceuticals Major industry is in the same range as KHTRF (90) in the null industry. This means that TAK’s stock grew similarly to KHTRF’s over the last 12 months.

KHTRF's Price Growth Rating (43) in the null industry is in the same range as TAK (58) in the Pharmaceuticals Major industry. This means that KHTRF’s stock grew similarly to TAK’s over the last 12 months.

TAK's P/E Growth Rating (18) in the Pharmaceuticals Major industry is significantly better than the same rating for KHTRF (97) in the null industry. This means that TAK’s stock grew significantly faster than KHTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TAK
RSI
ODDS (%)
Bullish Trend 2 days ago
48%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
46%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
40%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 12 days ago
44%
Declines
ODDS (%)
Bearish Trend 3 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
50%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

KHTRF and

Correlation & Price change

A.I.dvisor tells us that KHTRF and ESALF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KHTRF and ESALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KHTRF
1D Price
Change %
KHTRF100%
N/A
ESALF - KHTRF
27%
Poorly correlated
N/A
OVATF - KHTRF
25%
Poorly correlated
N/A
TAK - KHTRF
22%
Poorly correlated
+2.12%
JUSHF - KHTRF
13%
Poorly correlated
+2.65%
HYPMY - KHTRF
8%
Poorly correlated
+6.79%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
+2.12%
HLN - TAK
37%
Loosely correlated
+2.60%
ELAN - TAK
27%
Poorly correlated
+0.47%
RDY - TAK
25%
Poorly correlated
+1.77%
SNOA - TAK
24%
Poorly correlated
+3.58%
KHTRF - TAK
22%
Poorly correlated
N/A
More